These are all the clinical trials available. Choose a specialty if you want to narrow down the list.
Hepatitis C Virus in Pregnancy
Study Goal: to identify risk factors associated with mother to child transmission of HCV
(REF# 40221)
CMV in Pregnancy
Study Goal: to determine whether maternal administration of CMV hyperimmune globulin prior to 24 weeks gestation in women diagnosed with primary CMV infection reduces the rate of congenital CMV infection
(REF# 34414)
Tadalafil and Gastroparesis
FIXME
(REF# 00037289)
Ulcerative Colitis Study
Duke University Medical Center is conducting a research study to see if the experimental study drug, ASP3291, is safe and effective at controlling ulcerative colitis without causing significant side effects.
(REF# Pro00038948)
Parenting, Adolescent Self-Regulation, and Risk-Taking Across Cultures
Decision Making in Everyday Life.
(REF# 2032 (Duke University))
Comparing Focused Ultrasound and Uterine Artery Embolization for Uterine Fibroids
Duke will enroll 40 premenopausal African American women who are at least 25 years old in a clinical study examining ways to treat uterine fibroids.
(REF# 19054)
Are you currently pregnant via in-vitro fertilization (IVF)?
Researchers at Duke University School of Nursing are studying the stress levels in women and their partners who get pregnant with in-vitro fertilization (IVF) compared with women and their partners who get pregnant naturally.
(REF# Pro00039147)
Learning in Anorexia Nervosa
The purpose of this study is to learn more about the way individuals with eating disorders process information, which may help us develop new treatments.
(REF# Pro00034183)
Human Lung regional Ventilation Defect Severity measured by Fluorine-19 Gas MRI
An open label study in 250 subjects over five years. We are planning 130 subjects with COPD (varies stages of GOLD I-IV) and 120 normal subjects (non-smokers, ex smokers and current smokers with normal PFT’s).
(REF# 37791)
Dietary Nitrate to Augment Exercise Training Benefits in DM+PAD
We are seeking approximately 28 people (ages 40-80) with peripheral arterial disease and type II diabetes. This study is based at the Non-Invasive Vascular Laboratory at the Duke Center for Living campus.
(REF# Pro00039608)
